Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev Esp Enferm Dig ; 113(9): 684-685, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-33618534

RESUMO

We would like to congratulate Drs. Espinel and Pinedo for their excellent results in single-ballon enteroscopy-assisted ERCP recently published in REED(1).We also want to share our experience. Between 2015 and 2021 we have performed 31 procedures in 26 patients. Half of the procedures (45.16%) were performed in patients with Roux-en-Y hepatic jejunostomy. Eight of these (22.80%) had prior primary bile duct surgery and six (19.35%) had prior Whipple surgery. The other half of the procedures (54.8%) presented native papilla: 10 (32.25%) subtotal gastrectomy and seven (22.58%) gastric bypass surgery.


Assuntos
Colangiopancreatografia Retrógrada Endoscópica , Enteroscopia de Balão Único , Anastomose em-Y de Roux , Gastrectomia , Humanos , Estudos Retrospectivos
7.
Rev Esp Enferm Dig ; 108(5): 292-3, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26925975

RESUMO

Olmesartan is a therapy used for the management of hypertension available since 2002. A sprue like enteropathy associated with olmesartan has been first described in 2012. Endoscopic and histopathological findings are partial or total villous atrophy, mimicking a Celiac Disease. We explain two cases diagnosed in our hospital. Both patients took more than one year of treatment with olmesartan. In both cases, the biopsy showed duodenal villous atrophy, negative serology for celiac disease and they improved after stopping treatment with olmesartan. Olmesartan associate sprue-like enteropathy should be included in the differential diagnosis of seronegative villous atrophy. After the discontinuation of olmesartan, clinical remission usually occurs in every patients.


Assuntos
Bloqueadores do Receptor Tipo 1 de Angiotensina II/efeitos adversos , Doença Celíaca/induzido quimicamente , Imidazóis/efeitos adversos , Tetrazóis/efeitos adversos , Idoso , Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico , Doença Celíaca/diagnóstico por imagem , Humanos , Hipertensão/complicações , Hipertensão/tratamento farmacológico , Imidazóis/uso terapêutico , Masculino , Pessoa de Meia-Idade , Tetrazóis/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...